FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices

The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enabled medical devices, seeking feedback from interested parties on risk assessment, premarket evaluation, postmarket monitoring, and other topics